Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
Salt CompositionAceclofenac 100mg + Trypsin Chymotrypsin 50000IU
Prace-TC Tablet
You Searched
Prace-TC Tablet
H & Care Inc.
₹133
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Pain relief
Customers also bought
More About Prace-TC
Benefits
In Pain relief Prace-TC Tablet relieves pain, reduce swelling and ease inflammation in conditions like rheumatoid arthritis and osteoarthritis. It also helps to manage short term symptoms such as muscle and back pain, toothache, or pain in the ear and throat. It works by reducing substances in the body that cause pain and swelling. By reducing pain, it improves the quality of your life.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Prace-TC Tablet is to be taken with food.
How it works
Prace-TC Tablet is a combination of two medicines: Aceclofenac and Trypsin Chymotrypsin which relieve pain and inflammation. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) which works by blocking the release of certain chemical messengers in the brain that are responsible for pain, fever and inflammation (redness and swelling). Trypsin Chymotrypsin is a combination of enzymes which break down proteins into smaller fragments, thereby making them available for absorption into the blood. Once absorbed, they increase blood supply in the affected area and reduce swelling.
Unsafe: Avoid consuming alcohol with Prace-TC Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Prace-TC Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Information regarding the use of Prace-TC Tablet during breastfeeding is not available. Doctor consultation is advised.
Not Safe: Prace-TC Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Caution Advised: Prace-TC Tablet should be used with caution in patients with kidney disease. Dose adjustment of Prace-TC Tablet may be needed. Doctor consultation is advised. Use of Prace-TC Tablet is not recommended in patients with severe kidney disease.
Caution Advised: Prace-TC Tablet should be used with caution in patients with liver disease. Dose adjustment of Prace-TC Tablet may be needed. Doctor consultation is advised. Use of Prace-TC Tablet is not recommended in patients with severe liver disease. Regular monitoring of liver function tests is advisable while the patient is taking this medicine.
What if I forget to take it?
If a dose of Prace-TC Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
SCF- 250, Ground Floor,Motor Market, ManimajraChandigarh - 160101, India.
References
Shah D, Mital K. The Role of Trypsin:Chymotrypsin in Tissue Repair. Adv Ther. 2018;35(1):31-42 (02 Apr. 2019)
DailyMed. Aceclofenac (23 Apr. 2019)
ScienceDirect. Trypsin Chymotrypsin (02 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
